Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

Researchers believe the new method of assessing treatment responses could pave the way for developing new cancer therapeutics.

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

This study is one of the largest to date to assess brain growth in opioid-exposed fetuses in utero. 

As the population of patients with adult congenital heart disease grows, they are presenting to adult cardiology clinics and being imaged with CT. Many also do not have access or cannot be imaged by MRI, said Renee Bullock-Palmer, MD.

The results of a new trial offer “much needed progress” in the treatment of PD, experts involved in the study suggested. 

Also, up to 26% of eligible women have not had a formal conversation with their physician regarding their breast cancer risks, despite current guidelines that suggest these discussions start sooner rather than later.

Vaccination rates likely had a role in reducing disease severity during Omicron, a new paper published in Radiology suggests.